Related Experiment Videos
Hepatocellular carcinoma
1Division of Hematology and Oncology, University of California, San Francisco, 400 Parnassus Avenue, Suite 502, San Francisco, CA 94143, USA.
Current Treatment Options in Oncology
|June 12, 2002
Summary
Early detection of hepatocellular carcinoma (HCC) is possible in high-risk patients. However, HCC often presents as incurable, and current treatments for unresectable tumors show limited survival benefits.
Area of Science:
- Hepatology
- Oncology
- Gastroenterology
Background:
- Hepatocellular carcinoma (HCC) surveillance is feasible in at-risk populations.
- Optimal HCC surveillance strategies remain undetermined.
- HCC is frequently diagnosed at an incurable stage, even with surveillance.
Purpose of the Study:
- To review the current landscape of hepatocellular carcinoma detection and management.
- To discuss treatment options for unresectable HCC.
- To emphasize the importance of clinical trials for HCC treatment.
Main Methods:
- Review of existing literature on HCC surveillance and treatment.
- Analysis of surgical resection, transplantation, and ablative techniques.
- Evaluation of palliative therapies for unresectable HCC.
Main Results:
- Surgical resection is the preferred treatment but often not feasible due to disease extent and underlying liver conditions.
- Liver transplantation and ablative therapies offer curative potential for selected unresectable cases.
- Chemotherapy, hormonal therapy, and regional treatments provide palliative care but do not extend survival.
Conclusions:
- Early HCC detection is achievable, but curative treatment remains challenging.
- Management of unresectable HCC requires careful consideration of transplantation or ablative options.
- Participation in clinical trials is recommended for patients with HCC to explore novel therapies and improve outcomes.